A second impotence pill is up for approval by US drug regulators. If passed, Vasomax, manufactured by Texas-based Zonagen, will become the first direct competitor to Pfizer's blockbusting drug Viagra. The company submitted an application to have the drug approved to the US Food and Drug administration (FDA) on Wednesday 15 July. An FDA decision is not expected for months.